Frailty After Transarterial Chemoembolization for Hepatocellular Carcinoma: A Cross-Sectional Study of Incidence and Associated Factors
Journal of Multidisciplinary Healthcare · 2026-10 · Volume 19 · 1-9
DOI: 10.2147/jmdh.s601651 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Multidisciplinary Healthcare, 2026-10. Verfasst von Yuying Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Objective
To evaluate the incidence of and factors associated with frailty in hepatocellular carcinoma (HCC) patients after transarterial chemoembolization (TACE), with the objective to inform future personalized managements.
Methods
In this cross-sectional study conducted from January to October 2025, HCC patients undergoing TACE at a tertiary hospital in Suzhou were selected by convenience sampling and completed a general information questionnaire. The Fried frailty phenotype, Nutritional Risk Screening 2002 tool, and Barthel Index for activities of daily living were comprehensively evaluated between postoperative days 1 and 4 following TACE. Factors associated with frailty after TACE were identified via univariate and multivariate logistic regression analyses.
Results
Among the 312 included patients, 87 (27.9%) patients and 225 (72.1%) patients were in the frailty and non-frailty groups, respectively. Univariate analysis revealed statistically significant differences in age, sex, nutritional risk, Barthel Index, systemic immune-inflammatory index (SII), and hemoglobin level between the two groups (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, People's Republic of China.
Zitieren
APA
Lin, Y., Qian, D., Jiang, B., Zhang, S., & Li, T. (2026). Frailty After Transarterial Chemoembolization for Hepatocellular Carcinoma: A Cross-Sectional Study of Incidence and Associated Factors. Journal of Multidisciplinary Healthcare, Volume 19, 1-9. https://doi.org/10.2147/jmdh.s601651
Vancouver
Lin Y, Qian D, Jiang B, Zhang S, Li T. Frailty After Transarterial Chemoembolization for Hepatocellular Carcinoma: A Cross-Sectional Study of Incidence and Associated Factors. Journal of Multidisciplinary Healthcare. 2026;Volume 19:1-9. doi:10.2147/jmdh.s601651
BibTeX
@article{Lin2026,
author = {Lin, Yuying and Qian, Duo and Jiang, Bingxin and Zhang, Shanshan and Li, Tingting},
title = {Frailty After Transarterial Chemoembolization for Hepatocellular Carcinoma: A Cross-Sectional Study of Incidence and Associated Factors},
journal = {Journal of Multidisciplinary Healthcare},
year = {2026},
volume = {Volume 19},
pages = {1--9},
doi = {10.2147/jmdh.s601651}
}
EUVIMED